Repare Therapeutics Inc. RPTX
2.65 USD 0.00 (+0.00%)
At closeJan 28, 2026, 4:00 PM EST
2.64 -0.01 -0.37%
After hours · Jan 28, 4:00 PM ET
2.65 Day range 2.65
52-week range unavailable
- YTD
- +1.92%
- 1 year
- +130.43%
Analyst view
Consensus: buy
Buy
Price target (mean) 8.50 +220.8% upside
Now 2.65
- Target (low)
- 4.00
- Target (mean)
- 8.50
- Target (high)
- 15.00
Ratings (0m) 7 5 buy · 2 hold · 0 sell
- Strong buy2
- Buy3
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 8
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.78667 | -0.89 – -0.73 | -0.67 | -17.4% | 2.73M | -79.1% | 3 |
| Next quarter | -0.70667 | -0.76 – -0.61 | 0.30 | -335.6% | 2.34M | -95.5% | 3 |
| Current year | -2.13 | -2.22 – -2.03 | -2.23 | +4.7% | 55.73M | +9.0% | 2 |
| Next year | -2.84 | -3.25 – -2.63 | -2.13 | -33.8% | 6.72M | -87.9% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 13, 2024 | LifeSci Capital | Downgrade | Outperform | Market Perform |
| Dec 13, 2024 | Stifel | Maintained | Buy | Buy |
| Nov 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 24, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 23, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 4, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 5, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 21, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 14, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 20, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 16, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Sep 25, 2023 | Stifel | Maintained | Buy | Buy |
| Aug 17, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 9, 2023 | Stifel | Upgrade | Hold | Buy |
| Jun 9, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 27, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 17, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 27, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Feb 3, 2023 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Nov 17, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 8, 2022 | Morgan Stanley | Maintained | — | Overweight |
| Jun 6, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 2, 2022 | Piper Sandler | Maintained | — | Overweight |
| Apr 12, 2022 | Stifel | Downgrade | Buy | Hold |
| Sep 23, 2021 | Stifel | Initiated | — | Buy |
| Sep 13, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 16, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Jun 28, 2021 | Guggenheim | Initiated | — | Buy |